Bioactivity:

KBU2046 is an oral inhibitor of cell motility and cell invasion in vitro. It inhibits cancer metastasis and prolongs life. KBU2046 binds chaperone heterocomplexes, selectively alters binding of client proteins that regulate motility, and lacks all of the

CAS nr:

1143863-69-7

Purity:

98%

Molecular Weight:

242,25

SMILES:

O=C1C(C2=CC=C(F)C=C2)COC3=CC=CC=C13

Formula:

C15H11FO2

Pathway:

Others

Target:

Others